Projects

  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Sexual and Reproductive Health
  • Medicines in Europe
  • Prices, Availability & Affordability
  • Resources
  • Resources
  • Politics Of Medicines Encyclopaedia
  • COVID-19 Response
  • Partners for Change

Work With Us

  • Partners
  • Access to medicines movement
  • Work
  • Media
  • News
  • Media Resource

About

  • Mission, vision, core principles & impact
  • Financial info, statutes, policies & governance
  • Team
  • Testimonials
  • Contact us

Support our projects

Donate Join the Movement
AAA
Health Action International
  • Blog
  • Events

Donate

Projects

  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Sexual and Reproductive Health
  • Medicines in Europe
  • Prices, Availability & Affordability
  • Resources
  • Resources
  • Politics Of Medicines Encyclopaedia
  • COVID-19 Response
  • Partners for Change

Work With Us

  • Partners
  • Access to medicines movement
  • Work
  • Media
  • News
  • Media Resource

About

  • Mission, vision, core principles & impact
  • Financial info, statutes, policies & governance
  • Team
  • Testimonials
  • Contact us

Support our projects

Donate Join the Movement

Systematic review of drug promotion's influence on prescribing

Home > News > Systematic review of drug promotion's influence on prescribing

Share via:

  • Facebook
  • Twitter
  • LinkedIn
  • More

An important new systematic review on the content and effects of drug promotion is just out in PloS Medicine, featuring HAI Europe members Joel Lexchin and Peter Mansfield as co-authors.

Read the article Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians’ Prescribing: A Systematic Review

Tags
  • Rational Use of Medicines
Print or PDF
Print this page
Download PDF-file

Related News

  • HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World
  • Generic prescribing policies 1 - ABPI 0
  • Finnish study: Drug companies see added value of patient group sponsorship
  • European drug regulator challenged over revolving door case involving former Director
  • Independent drug bulletin and assessment reports from Spain - now in English
  • Intern Spotlight: A Year in Review
  • Review of conflict of interest policies in three European medicines regulation agencies
  • Tamiflu review shows desperate need for full clinical trials data transparency
  • A new (and improved) model to regulate pharmaceutical promotion
  • Week in review: Outcomes from WHA67
Join the movement

Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere

Donate Become a Member

Projects
  • Snakebite Treatment and Prevention
  • Access to Insulin
  • Sexual and Reproductive Health
  • Medicines in Europe
  • Prices, Availability & Affordability
About Us
  • Vision, Mission & Impact
  • History
  • Governance
Work With Us
  • Donate
  • Partner with us
  • Jobs & Internships
Contact Us

Health Action International
Overtoom 60 (2)
1054 HK Amsterdam

The Netherlands

+31 (0) 20 412 4523
info@haiweb.org

© 2021 Health Action International
  •  
Share via
Facebook
Twitter
LinkedIn
Mix
Email
Print
Copy Link
Powered by Social Snap
Copy link
CopyCopied
Powered by Social Snap
This website uses cookies to personalize the content and marketing of our website, to provide additional features and to analyze website traffic.Accept